Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study

Basit Öğe Kaydı
dc.contributor.authorYurdaydin, Cihan
dc.contributor.authorWedemeyer, Heiner
dc.contributor.authorCaruntu, Florin A.
dc.contributor.authorCurescu, Manuela G.
dc.contributor.authorYalcin, Kendal
dc.contributor.authorAkarca, Ulus S.
dc.contributor.authorGurel, Selim
dc.contributor.authorZeuzem, Stefan
dc.contributor.authorErhardt, Andreas
dc.contributor.authorLueth, Stefan
dc.contributor.authorPapatheodoridis, George V.
dc.contributor.authorPort, Kerstin
dc.contributor.authorKeskin, Onur
dc.contributor.authorRadu, Monica N.
dc.contributor.authorCelen, Mustafa K.
dc.contributor.authorIdilman, Ramazan
dc.contributor.authorStift, Judith
dc.contributor.authorMederacke, Ingmar
dc.contributor.authorHeidrich, Benjamin
dc.contributor.authorManns, Michael P.
dc.contributor.authorDienes, Hans Peter
dc.date.accessioned2019-10-27T21:41:00Z
dc.date.available2019-10-27T21:41:00Z
dc.date.issued2012
dc.departmentEge Üniversitesien_US
dc.description63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MAen_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage203Aen_US
dc.identifier.issn0270-9139
dc.identifier.startpage202Aen_US
dc.identifier.urihttps://hdl.handle.net/11454/46495
dc.identifier.volume56en_US
dc.identifier.wosWOS:000310955601024en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 studyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu